Search Results

You are looking at 1 - 2 of 2 items for

  • Author or Editor: I. A. Gardner x
  • Refine by Access: All Content x
Clear All Modify Search


We determined the extent of the serologic cross-reactivity in the indirect fluorescent antibody (ifa) test for Babesia gibsoni, and the optimal cut-off titer for seropositivity in the test. The lowest titer to B gibsoni detected in a dog with naturally acquired clinical babesiosis was 1,280, and 7 of 12 dogs had titer between 10,240 and 20,480. Two experimentally infected normosplenic dogs developed high titer (40,960 to 81,920) to B gibsoni, and the same sera reacted in ifa tests for B canis (titer ≤ 640), Toxoplasma gondii (titer ≤ 2,560), and Neospora caninum (titer ≤ 10,240). Dogs that were experimentally infected with B canis and T gondii had titer ≤ 160 to B gibsoni. Dogs that were experimentally infected with N caninum had titer (80 to 10,240) to N caninum, but failed to have serologic reactivity to B gibsoni. Serologic titer of healthy dogs from Australia, a country where B gibsoni is not known to exist, was ≤ 160 to B gibsoni. On the basis of these findings, a cut-off titer of 320 was considered to be appropriate for serodiagnosis of B gibsoni in dogs with clinical signs of babesiosis. A more conservative titer of 1,280 was established as the cut-off titer for seroepidemiologic studies based on relative costs and benefits of false-positive results and failure to isolate B gibsoni parasites after splenectomy and immunosuppression from a clinically normal dog with B gibsoni titer of 640. Results of the study indicate the importance of establishing optimal cut-off titer for the B gibsoni ifa test that takes into consideration the purpose of the test, seroreactivity to antigenically related parasites, and factors that contribute to interlaboratory test variation.

Free access
in American Journal of Veterinary Research


To investigate relationships of several racehorse characteristics and race conditions with risk of a catastrophic musculoskeletal injury (CMI) resulting in euthanasia in Thoroughbreds during racing in California in 1992.


Retrospective longitudinal study.


Thoroughbreds that incurred CMI during racing and all California race entrants in 1992.


Necropsy records were reviewed, and race start information was obtained. Incidence risk of CMI/1,000 race entrants was estimated. Relationships between CMI during racing and race-meet, entrant age and sex, race type and length, and racing surface type and condition were evaluated by use of logistic regression.


Incidence risk of CMI was 1.7/1,000 entrants. A higher risk of CMI was found at 2 fair race-meets, with incidence risks of 4.9 and 5.5/1,000 entrants. Risk of injury in male horses was 1.7 times greater than that in female horses, and influence of age on risk depended on race type. Risk of injury for horses 2 to 5 years old was two times greater for claiming horses than for maiden horses. Race length or racing surface type (dirt vs turf) or condition (fast, muddy, yielding) were not significantly associated with risk of CMI.

Clinical Implications

Incidence of CMI was similar among 12 of 14 major and fair race-meets and among various race lengths and racing surface types and conditions, whereas incidence of CMI was influenced by entrant age and sex as well as race type. Investigators should consider controlling for age and sex, race-meet, and race type whenever possible in studies of risk of CMI. (J Am Vet Med Assoc 1998; 212:544-549)

Free access
in Journal of the American Veterinary Medical Association